ADMS - Adamas Pharma EPS beats by $0.23 misses on revenue May, 07 2020 04:23 PM Adamas Pharmaceuticals Inc. Adamas Pharma (NASDAQ:ADMS): Q1 GAAP EPS of -$0.59 beats by $0.23.More news on: Adamas Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...